Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Infection and Immunity|April 20, 2006
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite proteinMichael Walther, Fiona M Thompson, Susanna Dunachie, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Nature Cardiovascular Research|September 13, 2024
Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillationVishal Vyas, Balraj Sandhar, Jack M Keane, et al.
The Journal of Infectious Diseases|July 3, 2009
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protectionKent E Kester, James F Cummings, Opokua Ofori-Anyinam, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2009
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by designKelley M VanBuskirk, Matthew T O'Neill, Patricia De La Vega, et al.
Vaccine|December 18, 2004
Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720Michael Walther, Susanna Dunachie, Sheila Keating, et al.
Vaccine|January 26, 2006
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CSSusanna J Dunachie, Michael Walther, Jenni M Vuola, et al.
Health Technology Assessment (Winchester, England)|October 19, 2021
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCTIan Roberts, Haleema Shakur-Still, Adefemi Afolabi, et al.
Scottish Medical Journal|January 18, 2021
Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we? - results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United KingdomHrishi Joshi, Gaurav Sali, Louise Paramore, et al.
Pageof 12